This could be just in addition to what he already has. Matt's not new to the Company.
For Type 1's Afrezza, Tresiba and a Dexcom device combination will send the pump into history fast. Pumps are a hassle to carry around. Who wants to be tethered to one everywhere you go? Afrezza and a Dexcom should dominate Type 2's
I don't think Audio is fake, he was convinced Sanofi wasn't backing out. He's a lot more grounded than most of the posters here. A balanced perspective is much better than nonsense all the time.
No he doesn't, he's struggling to beat Cruz. The fact that there are still 6 GOP Candidates at this point should tell you that there's something very wrong. The GOP is doing everything they can to take down Hillary, and if they are able to succeed, they'll just get something worse in return. Good ol Bernie ...
What are the losses at this point, there's virtually no spend at all on any advertising. There's only manufacturing and distribution costs, with the volume being so low that's got to be minimal, right? I would think manufacturing has been slowed to a crawl.
None, and more than one Tudiabetes posters have had their lungs checked after 6+ months on it and showed no changes at all.
Tesiba is a much better drug and will torpedo Toujeo market, it's already starting. It goes extremely well with Afrezza. Sanofi bet the wrong horse, only because it was home grown.
Sadly I agree, but it would be nice to hear that they are in talks with more then 1 party with several possibilities.